AI assistant
Sending…
Savara Inc — Director's Dealing 2010
Feb 4, 2010
32709_dirs_2010-02-03_8e144de0-d04a-41b8-a2dc-ce29499fbc03.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ADVENTRX PHARMACEUTICALS INC (ANX)
CIK: 0001160308
Period of Report: 2010-02-02
Reporting Person: Keran Patrick L (President, COO and Secretary)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-02-02 | Non-qualified Stock Option (Right to Buy) | $0.32 | A | 1600000 | Acquired | 2020-02-02 | Common Stock (1600000) | Direct |
Footnotes
F1: Twenty-five percent of the shares subject to this option vests and becomes exercisable on each of January 1, 2011, January 1, 2012, January 1, 2013 and January 1, 2014.
More from Savara Inc
Annual Report
2026
Apr 24
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 5
Regulatory Filings
2026
Jan 27
Regulatory Filings
2026
Jan 9
Director's Dealing
2025
Dec 19
Regulatory Filings
2025
Dec 18
Director's Dealing
2025
Dec 16